Become a Member

Search Results for: 2017

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] Ho ho ho! And Happy Christmas to all […]

This article was originally published on January 18, 2017. It has NOT been updated or revised since that date, the new versions of the ad we’re now seeing have dropped the “Retirement Blackout” pitch about April 10, since that fiduciary rule change was delayed in Washington, but otherwise the “26(f)” pitch appears unchanged. This ad […]

I’m always interested to see what kind of big-growth ideas are being teased, particularly in a market that already feels so expensive, so a Cabot pitch caught my eye again this week — this time it’s from Mike Cintolo for Cabot Growth Investor, and this is what grabbed my attention: “My Expectation: A 25% Jump […]

The latest ads from Cabot’s Global Stocks Explorer caught my eye with a “bypass the coronavirus” pitch. Here’s how the ad starts: “Bypass the Coronavirus…with this hidden gem at the heart of ‘the biggest investment boom in history’ “Operating revenue increased over 70%. “Gross profit surged 122%. “Net income was up over 60%. “Total bookings […]

I covered this teaser pitch from Marin Katusa as part of a Friday File for our Irregulars way back in February, and I’m getting buckets of questions about this “Forever Royalties” pitch again so I thought I should double check and update this — and share it with everyone, not just our paying members (yes, […]

Down 24.93% In the period from the 3rd of November up to including the 28th of March the stock went down 24.93% despite the 12% dividend growth and the 6% group revenue growth in 2017. Was the company really at its top performance in 2017 and is the price now thrown back to the real […]

Sometimes literary gimmicks backfire. In May 2015, we premiered “Cisco, Chang & Charlie” (sans Oxford comma) as a James Joycean brooding on the letter C, third letter of the alphabet, in three iterations. At the time, three stocks whose names begin with C were vying for attention and prompting questions from readers. The original plan […]

No, these bits won’t be about Melania’s kidney ailment nor yet about what Meghan wore for The Wedding.   I wish them both luck – they’ll need it!. However, there continue to be developments on the medical and health-care fronts that may matter to us a good deal more than the doings of those ladies.    […]

We’ve seen a long stream of earnings reports and other worthwhile bits of data on Real Money Portfolio stocks since I last wrote to you, including some that actually included some interesting news, so prepare for a lot of quick updates…. Medical Properties Trust (MPW) reported another quarter of ho-hum… pretty much met the forecasts, […]

I’ve gotten quite a few questions recently about “income” and “buy stocks cheap” letters that are clearly veiled hints about put option selling… so I thought I’d take a look at one of them. The ad in question today is from Karim Rahemtulla, who calls himself “The Frugal Millionaire” in this spiel and has been […]

We’ve got a big new cryptocurrency-related pitch to look at for you today, and since it’s from Ray Blanco at Agora’s Breakthrough Technology Alert, one of the most heavily-marketed newsletters around, you’ll probably see the ad soon if you haven’t already. It’s all about what Ray Blanco calls “The Stockchain” … which is basically the […]

Down 24.93% In the period from the 3rd of November up to including the 28th of March the stock went down 24.93% despite the 12% dividend growth and the 6% group revenue growth in 2017. Was the company really at its top performance in 2017 and is the price now thrown back to the real […]

[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]

The latest “ADC” pitch from Michael Robinson has generated a lot of questions from readers this week, and the ad itself seems to be pretty much a carbon copy of the one sent out back in December… so we’re just re-posting this teaser solution for you. What follows is unchanged from when it first appeared […]

1 2 3 4 5 9

Recent Comments

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info